# Scott M. Lippman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/scott-m-lippman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 64,376 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 114 |
| i10-index | 498 |
| Last Known Institution | University of San Diego |
| OpenAlex ID | https://openalex.org/A5069190968 |
| ORCID iD | https://orcid.org/0000-0002-1643-4124 |
| Works | 1,140 |

## Researcher papers

- [Lung Cancer](https://scholariq.org/papers/lung-cancer/)
- [An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance](https://scholariq.org/papers/an-epithelial-mesenchymal-transition-gene-signature-predicts-resistance-to-egfr/)
- [The BATTLE Trial: Personalizing Therapy for Lung Cancer](https://scholariq.org/papers/the-battle-trial-personalizing-therapy-for-lung-cancer/)
- [Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1](https://scholariq.org/papers/proteomic-profiling-identifies-dysregulated-pathways-in-small-cell-lung-cancer/)
- [Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome](https://scholariq.org/papers/effect-of-kras-oncogene-substitutions-on-protein-behavior-implications-for/)
- [Predicting cancer development in oral leukoplakia: ten years of translational research.](https://scholariq.org/papers/predicting-cancer-development-in-oral-leukoplakia-ten-years-of-translational/)
- [An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition](https://scholariq.org/papers/an-integrin-3-kras-ralb-complex-drives-tumour-stemness-and-resistance-to-egfr/)
- [Positive Surgical Margins in the 10 Most Common Solid Cancers](https://scholariq.org/papers/positive-surgical-margins-in-the-10-most-common-solid-cancers/)
- [Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward](https://scholariq.org/papers/progress-in-chemoprevention-drug-development-the-promise-of-molecular-biomarkers/)
- [Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial](https://scholariq.org/papers/pembrolizumab-plus-cetuximab-in-patients-with-recurrent-or-metastatic-head-and/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Retinoids in leukemia and cellular processes](https://scholariq.org/topics/retinoids-in-leukemia-and-cellular-processes/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)

## Researcher university

- [University of San Diego](https://scholariq.org/institutions/university-of-san-diego/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.